Penserra Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.02 - $13.33 $7,581 - $14,396	-1,080 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $169 - $249	15 Added 1.41%	1,080 $12,000
Q1 2021 May 13, 2021	SELL	$13.12 - $20.9 $131 - $209	-10 Reduced 0.93%	1,065 $19,000
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $6,192 - $9,838	679 Added 171.46%	1,075 $14,000
Q3 2020 Nov 13, 2020	BUY	$10.46 - $14.46 $4,142 - $5,726	396 New	396 $4,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.